Agrylin Drug Use-Result Survey
NCT03625895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1826
Last updated 2023-02-27
Summary
The objective of this survey is to collect data to evaluate the safety and efficacy of anagrelide hydrochloride in the post-marketing phase in participants diagnosed with Essential Thrombocythemia (ET).
Conditions
- Essential Thrombocythemia (ET)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-25
- Primary Completion
- 2021-03-11
- Completion
- 2021-03-11
Countries
- Japan
Study Locations
More Related Trials
-
EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
NCT00562588 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
NCT00508924 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
NCT03698513 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
NCT03615846 ·Status: UNKNOWN
-
AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
NCT01915407 ·Status: COMPLETED
-
Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA
NCT06591338 ·Status: RECRUITING ·Phase: PHASE3
-
Safety of High-dose Tirofiban During Coronary Angioplasty
NCT00566891 ·Status: COMPLETED ·Phase: PHASE4
-
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
NCT05257824 ·Status: COMPLETED ·Phase: PHASE4
-
Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients
NCT04861363 ·Status: UNKNOWN
-
Antiplatelet Drug Resistances and Ischemic Events
NCT00501423 ·Status: COMPLETED
-
The Prevention of Thromboembolic Complications Associated With Coil Embolization
NCT05512546 ·Status: COMPLETED
-
Low Dose Aspirin Studied With the AggreGuide
NCT01603966 ·Status: COMPLETED
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets
NCT01744288 ·Status: COMPLETED ·Phase: PHASE1
-
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
NCT04981041 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction
NCT02525081 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
NCT05986968 ·Status: RECRUITING ·Phase: NA
-
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease
NCT04132791 ·Status: TERMINATED ·Phase: NA
-
Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)
NCT03596502 ·Status: COMPLETED
-
ARISE - Aggressive Reduction of Inflammation Stops Events
NCT00066898 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prescription Support Tool for Oral Antithrombotic Combinations
NCT03630874 ·Status: COMPLETED ·Phase: NA
-
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
NCT03005704 ·Status: UNKNOWN ·Phase: NA
-
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
NCT03787927 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA
NCT06591312 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
NCT02929888 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3